Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
0.256 %
$ 349 M
Market Cap
-8.89
P/E
TRVI - ACCOUNTS PAYABLE
Accounts Payable TRVI - Trevi Therapeutics, Inc.
1.81 M
LAST VALUE
-20.32%
2 YEAR CAGR
24.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR